Pacific Biosciences Of California (PACB) Enterprise Value (2010 - 2026)

Pacific Biosciences Of California's Enterprise Value history runs 17 years deep, the most recent figure standing at -$276.0 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 19.57% year-over-year to -$276.0 million; the TTM figure through Mar 2026 stood at -$276.0 million (up 19.57% YoY), while the FY2025 annual figure was -$279.5 million, up 28.32% from the prior year.
• Enterprise Value was -$276.0 million for Q1 2026 at Pacific Biosciences Of California, up from -$279.5 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$55.1 million in Q2 2025 to a low of -$962.8 million in Q1 2022.
• Historically, Enterprise Value has averaged -$442.5 million across 5 years, with a median of -$354.1 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 87.97% in 2024, then slumped 279.62% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$772.3 million in 2022, then increased by 18.24% to -$631.4 million in 2023, then jumped by 38.24% to -$389.9 million in 2024, then grew by 28.32% to -$279.5 million in 2025, then advanced by 1.27% to -$276.0 million in 2026.
• The last three Enterprise Value figures came in at -$276.0 million (Q1 2026), -$279.5 million (Q4 2025), and -$298.7 million (Q3 2025), per Business Quant data.